Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.

Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Abstract Text:

    lan guoLan Guo,yan maYan Ma,rebecca wardRebecca Ward,vince castranovaVince Castranova,xianglin shiXianglin Shi,yong qianYong Qian,

    PURPOSE: Individualized therapy of lung adenocarcinoma depends on the accurate classification of patients into subgroups of poor and good prognosis, which reflects a different probability of disease recurrence and survival following therapy. However, it is currently impossible to reliably identify specific high-risk patients. Here, we propose a computational model system which accurately predicts the clinical outcome of individual patients based on their gene expression profiles. EXPERIMENTAL DESIGN: Gene signatures were selected using feature selection algorithms random forests, correlation-based feature selection, and gain ratio attribute selection. Prediction models were built using random committee and Bayesian belief networks. The prognostic power of the survival predictors was also evaluated using hierarchical cluster analysis and Kaplan-Meier analysis. RESULTS: The predictive accuracy of an identified 37-gene survival signature is 0.96 as measured by the area under the time-dependent receiver operating curves. The cluster analysis, using the 37-gene signature, aggregates the patient samples into three groups with distinct prognoses (Kaplan-Meier analysis, P < 0.0005, log-rank test). All patients in cluster 1 were in stage I, with N0 lymph node status (no metastasis) and smaller tumor size (T1 or T2). Additionally, a 12-gene signature correctly predicts the stage of 94.2% of patients. CONCLUSIONS: Our results show that the prediction models based on the expression levels of a small number of marker genes could accurately predict patient outcome for individualized therapy of lung adenocarcinoma. Such an individualized treatment may significantly increase survival due to the optimization of treatment procedures and improve lung cancer survival every year through the 5-year checkpoint.

    Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Publishing Authors By Initials

    l guoL Guo,y maY Ma,r wardR Ward,v castranovaV Castranova,x shiX Shi,y qianY Qian,

    For similar natural sciences: time: time factors research abstracts see: natural sciences: time: time factors research

    PUBMED ID PMID:

    MEDLINE DATE:

    Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Clinical cancer research : an official journal of

    VOLUME: 12

    Page Numbers: 3344-54

    Journal Abbreviation: Clin. Cancer Res.

    ISSN: 1078-0432

    DAY: 1

    MONTH: Jun

    YEAR: 2006

    Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502500

    Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Keywords Mesh Terms:

    KEYWORDS: Time Factors

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.

    AFFILIATION: Mary Babb Randolph Cancer Center, Department of Community Medicine, West Virginia University, Morgantown, West Virginia 26506-9300, USA. lguo@hsc.wvu.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: P20 RR16440-03

    ACRONYM: RR

    MEDLINETA: Clin Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News